These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 4035138)

  • 1. [Standardization of Quick's time].
    Capel P; Fondu P
    Rev Med Brux; 1985 Jun; 6(6):393-6. PubMed ID: 4035138
    [No Abstract]   [Full Text] [Related]  

  • 2. International Committee for Standardization in Haematology, International Committee on Thrombosis and Haemostasis: ICSH/ICTH recommendations for reporting prothrombin time in oral anticoagulant control.
    Thromb Haemost; 1985 Feb; 53(1):155-6. PubMed ID: 3992515
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical impact of the standardization of Quick's time].
    de Moerloose P
    Schweiz Rundsch Med Prax; 1988 Aug; 77(34):865-6. PubMed ID: 3175419
    [No Abstract]   [Full Text] [Related]  

  • 4. [How to improve the monitoring of anticoagulant therapy with antivitamins K. Recommendation of the Study Group on Hemostasis and Thrombosis].
    Rev Fr Gynecol Obstet; 1987 Feb; 82(2):133-4. PubMed ID: 3563287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. International Committee for Standardization in Haematology/International Committee on Thrombosis and Haemostasis: ICSH/ICTH recommendations for reporting prothrombin time in oral anticoagulant control.
    Scand J Haematol; 1984 Oct; 33(4):397-8. PubMed ID: 6505637
    [No Abstract]   [Full Text] [Related]  

  • 6. [Quick's time and derived times in the study of the extrinsic course of the coagulation process. The PIVKA (protein induced by vitamin K absence or antagonists) in states of chronic disseminated intravascular coagulation].
    Moscarella S; Ventimiglia V
    Quad Sclavo Diagn; 1974 Dec; 10(4):463-73. PubMed ID: 4460075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral anticoagulants.
    Winter JH; Douglas AS
    Clin Haematol; 1981 Jun; 10(2):459-80. PubMed ID: 7032784
    [No Abstract]   [Full Text] [Related]  

  • 8. [External quality control and standardization of prothrombin time determination for the monitoring of oral anticoagulant treatment in the Netherlands].
    van Duuk-Wierda CA; Loeliger EA; Roos J
    Ned Tijdschr Geneeskd; 1980 Jan; 124(4):103-7. PubMed ID: 7374832
    [No Abstract]   [Full Text] [Related]  

  • 9. Standardization of the prothrombin time--finally.
    Koepke JA; Triplett DA
    Arch Pathol Lab Med; 1985 Sep; 109(9):800-1. PubMed ID: 3839650
    [No Abstract]   [Full Text] [Related]  

  • 10. [Toward better monitoring of anticoagulant treatment with antivitamins K. Recommendations of the Hemostasis and Thrombosis Study Group].
    Ann Cardiol Angeiol (Paris); 1986 Oct; 35(8):499-500. PubMed ID: 3813457
    [No Abstract]   [Full Text] [Related]  

  • 11. [Recommendations of the Hemostasis and Thrombosis Study Group. Toward better monitoring of anticoagulant treatment with antivitamins K].
    Ann Med Interne (Paris); 1986; 137(6):530-1. PubMed ID: 3813290
    [No Abstract]   [Full Text] [Related]  

  • 12. [Recommendation of the Group for Studies on Hemostasis and Thrombosis. Toward better supervision of anticoagulant therapy by anti-vitamin K agents].
    Pathol Biol (Paris); 1986 Nov; 34(9):1035-6. PubMed ID: 3543814
    [No Abstract]   [Full Text] [Related]  

  • 13. Quick on Quick's test.
    Quick AJ
    N Engl J Med; 1973 May; 288(20):1079. PubMed ID: 4696624
    [No Abstract]   [Full Text] [Related]  

  • 14. [Monitoring of treatment with vitamin K antagonists: a plea for "INR" (International Normalized Ratio)].
    Lecompte T; Samama MM
    Rev Prat; 1990 Feb; 40(6):563-5. PubMed ID: 2320884
    [No Abstract]   [Full Text] [Related]  

  • 15. [Recommendations of the Hemostasis and Thrombosis Study Group. For better surveillance of anticoagulant therapy by anti-vitamin K agents].
    Nouv Rev Fr Hematol (1978); 1986; 28(5):331-2. PubMed ID: 3808944
    [No Abstract]   [Full Text] [Related]  

  • 16. [Oral anticoagulants: their pharmacology, mechanism of action and therapeutic control].
    Mariani G
    G Ital Cardiol; 1990 Jul; 20(7):653-60. PubMed ID: 2245906
    [No Abstract]   [Full Text] [Related]  

  • 17. The response of Quick's prothrombin time test to oral anticoagulation. Influence of thromboplastin source and calcium chloride concentration.
    van den Besselaar AM
    Arch Pathol Lab Med; 1994 Feb; 118(2):145-9. PubMed ID: 8311653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparison between the dilution curves of prothrombin time and activated partial thromboplastin time for the control of the effect of anti-vitamin K].
    Langer B; Fuess VL; Kauffman P; Bechara MJ; dos Reis JM; Kwang WT
    Rev Hosp Clin Fac Med Sao Paulo; 1984; 39(1):18-22. PubMed ID: 6385200
    [No Abstract]   [Full Text] [Related]  

  • 19. Anticoagulant treatment of venous thromboembolism.
    Coon WW
    Surg Annu; 1972; 4():151-63. PubMed ID: 4668856
    [No Abstract]   [Full Text] [Related]  

  • 20. Artificially depleted plasmas are not necessarily commutable with native patient plasmas for International Sensitivity Index calibration and International Normalized Ratio derivation: a rebuttal.
    Fattorini A; Crippa L; D'Angelo A
    J Thromb Haemost; 2012 Aug; 10(8):1715-6. PubMed ID: 22642315
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.